Courses

Current Strategies, Diagnostic Approaches, and Advanced Therapeutics for the Treatment of Patients with Interstitial Lung Disease

Current Strategies, Diagnostic Approaches, and Advanced Therapeutics for the Treatment of Patients with Interstitial Lung Disease

This CME/CE symposium is derived from content presented at the Congress of Clinical Rheumatology East Meeting and will highlight recent advances in the treatment and management of patients with interstitial lung disease (ILD). The expert faculty, Drs. Dinesh Khanna and Kevin Flaherty, will first review best practices for screening and diagnosing patients. Following, recent clinical trial data of both emerging ...
View Course

New Challenges for the Advanced Practitioner for Optimal Patient Education

In this module, Jamie Faber, PA-C, along with Scott Kopetz, MD, PhD, course chair, will first delve into the practical considerations of biomarker testing for the interprofessional team. The expert faculty will also provide an overview of ctDNA, including the clinical implications in the colorectal cancer landscape. Following, best practices for managing adverse events to improve patient outcomes will be ...
View Course
Post Conference Review and Analysis of mCRC Data from ESMO GI 2021

Post Conference Review and Analysis of mCRC Data from ESMO GI 2021

In this module, Michael Sangmin Lee, MD, along with Scott Kopetz, MD, PhD, course chair, will review data presented at the ESMO World Congress on Gastrointestinal Cancer 2021 Meeting. The faculty will outline a few key studies from the meeting, focusing on populations such as those who were previously untreated and patients who received prior bevacizumab treatment. Current topics such ...
View Course
Post Conference Review and Analysis of mCRC Data from ASCO 2021

Post Conference Review and Analysis of mCRC Data from ASCO 2021

In this module, Michael Overman, MD, along with Scott Kopetz, MD, PhD, course chair, will highlight information presented at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting. The faculty will first analyze data regarding frontline metastatic colorectal cancer (mCRC), including the Keynote 177 and FOCUS 4N studies. Following, updates for both second-line mCRC and refractory mCRC therapeutics will ...
View Course
Review of Targeted Therapeutic Options for BRAF-Mutated Metastatic Colorectal Cancer, Including Combination Therapies

Review of Targeted Therapeutic Options for BRAF-Mutated Metastatic Colorectal Cancer, Including Combination Therapies

In this module, Benny Johnson, DO, along with Scott Kopetz, MD, PhD, course chair, will analyze targeted therapeutic options for BRAF-mutated metastatic colorectal cancer, with a focus on combination therapies. The faculty will highlight the pathway to precision therapy for BRAFV600E mutant metastatic colorectal cancer (mCRC), debating the clinical implications of recent trial data in an interactive panel format. Upon ...
View Course
Update on Optimal Biomarker and Genomic Testing for Colorectal Cancer, Including BRAF Mutations

Update on Optimal Biomarker and Genomic Testing for Colorectal Cancer, Including BRAF Mutations

In this module, Christopher Lieu, MD, along with Scott Kopetz, MD, PhD, course chair, will first discuss the current landscape of genomic testing for metastatic colorectal cancer (mCRC), highlighting the changes in the last decade. Following, the faculty will analyze testing options, covering topics such as gene sequencing, genomic profiling and liquid biopsy and circulating tumor DNA. To conclude, the ...
View Course
Novel Treatment Strategies for Sphingosine-1-Phosphate Therapeutics to Manage Patients with Moderate to Severe Ulcerative Colitis

Novel Treatment Strategies for Sphingosine-1-Phosphate Therapeutics to Manage Patients with Moderate to Severe Ulcerative Colitis

This CME/CE activity will highlight novel treatment strategies for sphingosine-1-phosphate (S1P) therapeutics to manage patients with moderate to severe ulcerative colitis (UC). The expert faculty, led by Dr. David T. Rubin, will first review the need for new therapeutics in ulcerative colitis, including treatment goals and unmet needs. Next, the faculty will analyze the science of S1P receptor modulators as ...
View Course
Applying S1P Therapeutics to Improve Outcomes for Patients with Moderate to Severe Ulcerative Colitis

Applying S1P Therapeutics to Improve Outcomes for Patients with Moderate to Severe Ulcerative Colitis

This CME activity is derived from content presented at the Digestive Disease Week (DDW) 2021 Virtual Meeting. The expert faculty will highlight sphingosine-1-phosphate (S1P) therapeutics to improve outcomes for patients with moderate to severe ulcerative colitis (UC). Additionally, a review of S1P receptor modulators as a therapeutic target to support the management of ulcerative colitis will be discussed. The faculty ...
View Course
Applying New Science to Patient-Focused Treatment Strategies Across the Spectrum of Multiple Sclerosis

Applying New Science to Patient-Focused Treatment Strategies Across the Spectrum of Multiple Sclerosis

This CME/CE activity is derived from content presented at the 6th Annual Advanced Curriculum for Multiple Sclerosis 2021 Virtual CME/CE Course. The expert faculty, led by Dr. Fred D. Lublin, will first review the science of the evolving spectrum of multiple sclerosis (MS) to better understand the course of MS disease activity, as well as optimal treatment solutions to reduce ...
View Course